Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Genitourinary Cancers
How are you integrating Prostox into your practice for prostate patients deciding between SBRT and hypofractionation?
Related Questions
Is there any way to safely treat patients with mCRPC with 177-Lu PSMA who are on hemodialysis?
What adjuvant treatment would you offer a patient who underwent cystoprostatectomy for a muscle invasive bladder cancer and discovered to also have prostate cancer?
How do you reconcile discordant PSMA and MRI findings in patients undergoing definitive radiotherapy for prostate cancer?
How do you manage bladder spasms during pelvic radiotherapy?
How do you contour your elective obturator lymph node volume?
In post-prostatectomy patients where urinary continence is never achieved, how and when would you plan RT when it is clinically indicated?
How do you manage significant gas in patients undergoing pelvic radiotherapy?
How often do you utilize intrafraction motion tracking when treating prostate cancer?
How do you manage prostate cancer in patients that cannot swallow pills?
Is there any evidence that ivermectin suppresses the PSA level in prostate cancer?
